Co-targeting PI3K, mTOR, and IGF1R with small molecule inhibitors for treating undifferentiated pleomorphic sarcoma

Caitlin D. MayDepartment of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;The University of Texas Health Science Center at Houston, Graduate School of Biomedical Sciences, Houston, TX, USA

Sharon M. LandersDepartment of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Svetlana BolshakovDepartment of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

XiaoYan MaDepartment of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Davis R. IngramDepartment of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Christine M. KivlinDepartment of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;The University of Texas Health Science Center at Houston, Graduate School of Biomedical Sciences, Houston, TX, USA

Kelsey L. WatsonDepartment of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Ghadah A. Al SannaaDepartment of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Angela D. BhallaDepartment of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Wei-Lien WangDepartment of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Alexander J. LazarThe University of Texas Health Science Center at Houston, Graduate School of Biomedical Sciences, Houston, TX, USA;Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

http://orcid.org/0000-0002-6395-4499

Keila E. TorresDepartment of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;The University of Texas Health Science Center at Houston, Graduate School of Biomedical Sciences, Houston, TX, USACorrespondence[email protected]

http://orcid.org/0000-0002-1855-0989

show all

Co-targeting PI3K, mTOR, and IGF1R with small molecule inhibitors for treating undifferentiated pleomorphic sarcoma

2017CBT10318R-file002.docx

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Co-targeting PI3K, mTOR, and IGF1R with small molecule inhibitors for treating undifferentiated pleomorphic sarcoma

2017CBT10318R-file002.docx

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date